Singapore markets closed
Straits Times Index
3,303.19 +10.26 (+0.31%) S&P 500
5,127.79 +63.59 (+1.26%) Dow
38,675.68 +449.98 (+1.18%) Nasdaq
16,156.33 +315.33 (+1.99%) Bitcoin USD
64,248.58 +571.45 (+0.90%) CMC Crypto 200
1,382.03 +69.40 (+5.29%)
PRTA May 2024 30.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:07AM EDT. Market open.
| Previous close | 7.60 |
| Open | 7.60 |
| Bid | 6.50 |
| Ask | 8.60 |
| Strike | 30.00 |
| Expiry date | 2024-05-17 |
| Day's range | 7.60 - 7.60 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
Business WireProthena to Report First Quarter 2024 Financial Results on May 8
DUBLIN, Ireland, May 01, 2024--Prothena announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
ZacksEarnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireProthena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
© 2024 Yahoo. All rights reserved.